Antiretroviral therapy coverage in Pre-demographic dividend

Pre-demographic dividend: Antiretroviral therapy coverage was 82.2% in 2024. ◆ Volatile

Latest (2024)
82.2%
Change on year
up 4.9%
Rank
11th
of 23 groups
All-time high
82.2%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage in Pre-demographic dividend, 2000–2024

0204060802000201220242000: 0.002 % of people living with HIV2001: 0.087 % of people living with HIV2002: 0.24 % of people living with HIV2003: 0.506 % of people living with HIV2004: 1.9 % of people living with HIV2005: 3.4 % of people living with HIV2006: 6 % of people living with HIV2007: 9.2 % of people living with HIV2008: 13.1 % of people living with HIV2009: 16.7 % of people living with HIV2010: 20.2 % of people living with HIV2011: 23.6 % of people living with HIV2012: 28.6 % of people living with HIV2013: 33.8 % of people living with HIV2014: 39.5 % of people living with HIV2015: 44.7 % of people living with HIV2016: 50 % of people living with HIV2017: 56 % of people living with HIV2018: 58.9 % of people living with HIV2019: 62.7 % of people living with HIV2020: 66.8 % of people living with HIV2021: 70.9 % of people living with HIV2022: 74.8 % of people living with HIV2023: 78.4 % of people living with HIV2024: 82.2 % of people living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.

Analysis

In 2024, antiretroviral therapy coverage in Pre-demographic dividend stood at 82.2%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 4.9% on the previous year and up 108.2% over ten years.

Over the whole period, antiretroviral therapy coverage in Pre-demographic dividend peaked at 82.2% in 2024 and was at its lowest, 0.0%, in 2000.

That places Pre-demographic dividend 11th out of 23 groups with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage in Pre-demographic dividend, year by year

Annual values for Antiretroviral therapy coverage (% of people living with HIV) in Pre-demographic dividend, 2000 to 2024.
Year % of people living with HIV Change
2000 0.0%
2001 0.1% +5277.9%
2002 0.2% +175.0%
2003 0.5% +110.9%
2004 1.9% +280.5%
2005 3.4% +79.0%
2006 6.0% +74.0%
2007 9.2% +53.9%
2008 13.1% +42.2%
2009 16.7% +27.2%
2010 20.2% +21.1%
2011 23.6% +16.7%
2012 28.6% +20.9%
2013 33.8% +18.5%
2014 39.5% +16.7%
2015 44.7% +13.2%
2016 50.0% +12.0%
2017 56.0% +12.0%
2018 58.9% +5.0%
2019 62.7% +6.6%
2020 66.8% +6.5%
2021 70.9% +6.2%
2022 74.8% +5.5%
2023 78.4% +4.8%
2024 82.2% +4.9%

Biggest year-on-year movements

Years where Antiretroviral therapy coverage in Pre-demographic dividend changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2001 +5277.9% 0.0% 0.1%
2004 +280.5% 0.5% 1.9%
2002 +175.0% 0.1% 0.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.1% 0.0% 16.7% 10
2010s 41.8% 20.2% 62.7% 10
2020s 74.6% 66.8% 82.2% 5

Countries ranked near Pre-demographic dividend

  1. 11 Burundi 93.0% compare
  2. 11 Germany 93.0% compare
  3. 11 Saudi Arabia 93.0% compare
  4. 14 Cambodia 92.0% compare
  5. 14 Denmark 92.0% compare
  6. 14 Togo 92.0% compare

See the full ranking of 166 places →

More health data for Pre-demographic dividend

All data for Pre-demographic dividend →

Frequently asked questions

What is antiretroviral therapy coverage in Pre-demographic dividend?
Antiretroviral therapy coverage in Pre-demographic dividend was 82.2% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage recorded in Pre-demographic dividend?
The highest recorded value was 82.2% in 2024.
What is the lowest antiretroviral therapy coverage recorded in Pre-demographic dividend?
The lowest recorded value was 0.0% in 2000.
How does Pre-demographic dividend rank for antiretroviral therapy coverage?
Pre-demographic dividend ranks 11th out of 23 groups with data for 2024.
Is antiretroviral therapy coverage rising or falling in Pre-demographic dividend?
Over the last ten years it is up 108.2%. The long-run trend across the full record is volatile.
Where does this Pre-demographic dividend data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage in Pre-demographic dividend. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 13 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/pre-demographic-dividend/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/pre-demographic-dividend/">Antiretroviral therapy coverage in Pre-demographic dividend</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.